PP_1170x120_10-25-21

AbbVie Inc.’s Norvir

Aurobindo receives FDA approval for ritonavir tablets

Aurobindo receives FDA approval for ritonavir tablets

EAST WINDSOR, N.J. — Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ritonavir tablets USP, 100 mg. Aurobindo’s ritonavir tablets are an AB-rated generic equivalent to the reference listed drug, AbbVie Inc.’s Norvir. Ritonavir is in a class of medications called protease inhibitors. Protease

Adheris Health